Lipohypertrophy and Insulin : An Update From the Diabetes Technology Society

Lipohypertrophy is a common skin complication associated with insulin-treated diabetes. The impact of lipohypertrophy as a contributing factor to suboptimal glycemic control, glucose variability, and hypoglycemia is often under-recognized by health care professionals. In a recent Webinar on April 26, 2023, Diabetes Technology Society asked international experts to provide updates on the latest knowledge related to lipohypertrophy for practicing clinicians and educators, researchers, and industries involved in insulin delivery. A recording of the Webinar is freely available on the Diabetes Technology Society Web site (https://www.diabetestechnology.org/).

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Journal of diabetes science and technology - 17(2023), 6 vom: 09. Nov., Seite 1711-1721

Sprache:

Englisch

Beteiligte Personen:

Tian, Tiffany [VerfasserIn]
Aaron, Rachel E [VerfasserIn]
Huang, Jingtong [VerfasserIn]
Yeung, Andrea M [VerfasserIn]
Svensson, Jannet [VerfasserIn]
Gentile, Sandro [VerfasserIn]
Forbes, Angus [VerfasserIn]
Heinemann, Lutz [VerfasserIn]
Seley, Jane Jeffrie [VerfasserIn]
Kerr, David [VerfasserIn]
Klonoff, David C [VerfasserIn]

Links:

Volltext

Themen:

Diabetes
Diabetes education
Glucose management
Hypoglycemic Agents
Insulin
Insulin, Regular, Human
Journal Article
Lipohypertrophy
Research Support, Non-U.S. Gov't
Ultrasound

Anmerkungen:

Date Completed 02.11.2023

Date Revised 22.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1177/19322968231187661

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360548989